PTGS2 and Parkinson disease: Mouse cyclooxygenase-2 was chosen for 1,4-NQ molecular docking because we tested enzyme activity in mouse RAW 264.7 macrophage cells and carried out further studies in vivo in mouse models of Parkinson’s disease.